Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
BACKGROUND: A recent increase in Bordetella pertussis without the pertactin protein, an acellular vaccine immunogen, has been reported in the United States. Determining whether pertactin-deficient (PRN(-)) B. pertussis is evading vaccine-induced immunity or altering the severity of illness is needed. METHODS: We retrospectively assessed for associations between pertactin production and both clinical presentation and vaccine history. Cases with isolates collected between May 2011 and February 2013 from 8 states were included. We calculated unadjusted and adjusted odds ratios (ORs) using multivariable logistic regression analysis. RESULTS: Among 753 isolates, 640 (85%) were PRN(-). The age distribution differed between cases caused by PRN(-) B. pertussis and cases caused by B. pertussis producing pertactin (PRN(+)) (P = .01). The proportion reporting individual pertussis symptoms was similar between the 2 groups, except a higher proportion of PRN(+) case-patients reported apnea (P = .005). Twenty-two case-patients were hospitalized; 6% in the PRN(+) group compared to 3% in the PRN(-) group (P = .11). Case-patients having received at least 1 pertussis vaccine dose had a higher odds of having PRN(-) B. pertussis compared with unvaccinated case-patients (adjusted OR = 2.2; 95% confidence interval [CI], 1.3-4.0). When restricted to case-patients at least 1 year of age and those age-appropriately vaccinated, the adjusted OR increased to 2.7 (95% CI, 1.2-6.1). CONCLUSIONS: The significant association between vaccination and isolate pertactin production suggests that the likelihood of having reported disease caused by PRN(-) compared with PRN(+) strains is greater in vaccinated persons. Additional studies are needed to assess whether vaccine effectiveness is diminished against PRN(-) strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mattoo, S., & Cherry, J. D. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.326-382.2005 · Cited by 1,138 · cited 1×
“Acellular vaccines including pertactin generally had greater efficacy in licensure trials than those without [26–31], although the actual role of pertactin and antibodies directed against it remains unclear.”
BackgroundWarfel, J. M., Zimmerman, L. I., & Merkel, T. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314688110 · Cited by 644 · cited 1×
“Additionally, data from a nonhuman primate model indicate that acellular vaccines may not prevent infection, although they can prevent disease symptoms [24].”
BackgroundWaning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children
Klein, N. P., Bartlett, J., Rowhani-Rahbar, A., Fireman, B., & Baxter, R. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200850 · Cited by 581 · cited 2×
“Although recently conducted effectiveness studies provide evidence that acellular vaccines continue to provide good protection against pertussis in the short term [3, 5, 34], additional studies are needed to further assess whether effectiveness or durability of protection of acellular vaccine is diminished against PRN…”
BackgroundBordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence
Mooi, F. R., van Loo, I. H. M., van Gent, M., He, Q., Bart, M. J., Heuvelman, K. J., de Greeff, S. C., Diavatopoulos, D., Teunis, P., Nagelkerke, N., et al. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1508.081511 · Cited by 351 · cited 1×
“culating Bordetella pertussis strains are undergoing genetic changes that may allow the organism to evade vaccine-induced immunity or be more virulent [6–10], which may be contributing to the increasing rates of”
BackgroundNumber and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection
Sheridan, S. L., Ware, R. S., Grimwood, K., & Lambert, S. B. (2012) · JAMA · doi:10.1001/jama.2012.6364 · Cited by 270
Misegades, L. K., Winter, K., Harriman, K., Talarico, J., Messonnier, N. E., Clark, T. A., & Martin, S. W. (2012) · JAMA · doi:10.1001/jama.2012.14939 · Cited by 248
Self-citationWaning Immunity to Pertussis Following 5 Doses of DTaP
Tartof, S. Y., Lewis, M., Kenyon, C., White, K., Osborn, A., Liko, J., Zell, E., Martin, S., Messonnier, N. E., Clark, T. A., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-1928 · Cited by 224 · cited 1×
“Waning immunity from acellular pertussis vaccines appears to be a significant factor leading to the increasing incidence [3–5].”
BackgroundSelf-citationPawloski, L. C., Queenan, A. M., Cassiday, P. K., Lynch, A. S., Harrison, M. J., Shang, W., Williams, M. M., Bowden, K. E., Burgos-Rivera, B., Qin, X., et al. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00717-13 · Cited by 221
Self-citationComparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers
Klein, N. P., Bartlett, J., Fireman, B., Rowhani-Rahbar, A., & Baxter, R. (2013) · Pediatrics · doi:10.1542/peds.2012-3836 · Cited by 196 · cited 1×
“Although recently conducted effectiveness studies provide evidence that acellular vaccines continue to provide good protection against pertussis in the short term [3, 5, 34], additional studies are needed to further assess whether effectiveness or durability of protection of acellular vaccine is diminished against PRN…”
BackgroundBouchez, V., Brun, D., Cantinelli, T., Dore, G., Njamkepo, E., & Guiso, N. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.074 · Cited by 174 · cited 2×
“Bordetella pertussis isolates lacking pertactin production have been reported at low frequencies from Italy [19], France [20], Japan [13], and Finland [14] and at Received 1 August 2014; accepted 23 September 2014; electronically published 9 October 2014.”
Background
Cited by
Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States
Aloe, C., Kulldorff, M., & Bloom, B. R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700240114 · Cited by 51
Metadata
- Authors
- Martin, S. W., Pawloski, L., Williams, M., Weening, K., DeBolt, C., Qin, X., Reynolds, L., Kenyon, C., Giambrone, G., Kudish, K., Miller, L., Selvage, D., Lee, A., Skoff, T. H., Kamiya, H., Cassiday, P. K., Tondella, M. L., & Clark, T. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-10-09
- Volume
- 60
- Issue
- 2
- Pages
- 223-227
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2146200722
- Cited by
- 194
- References
- 21
- FWCI
- 19.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.